187 related articles for article (PubMed ID: 29077935)
1. Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.
Kashyap SR; Osme A; Ilchenko S; Golizeh M; Lee K; Wang S; Bena J; Previs SF; Smith JD; Kasumov T
J Clin Endocrinol Metab; 2018 Feb; 103(2):388-396. PubMed ID: 29077935
[TBL] [Abstract][Full Text] [Related]
2. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus.
Liu D; Ji L; Zhao M; Wang Y; Guo Y; Li L; Zhang D; Xu L; Pan B; Su J; Xiang S; Pennathur S; Li J; Gao J; Liu P; Willard B; Zheng L
J Mol Cell Cardiol; 2018 Sep; 122():47-57. PubMed ID: 30092227
[TBL] [Abstract][Full Text] [Related]
3. Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism.
Domingo-Espín J; Nilsson O; Bernfur K; Del Giudice R; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2822-2834. PubMed ID: 29802959
[TBL] [Abstract][Full Text] [Related]
4. 2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice.
Kasumov T; Willard B; Li L; Li M; Conger H; Buffa JA; Previs S; McCullough A; Hazen SL; Smith JD
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1994-2003. PubMed ID: 23766259
[TBL] [Abstract][Full Text] [Related]
5. Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes.
Kheniser KG; Osme A; Kim C; Ilchenko S; Kasumov T; Kashyap SR
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235466
[TBL] [Abstract][Full Text] [Related]
6. Nonenzymatic glycation of high-density lipoprotein impairs its anti-inflammatory effects in innate immunity.
Liu D; Ji L; Zhang D; Tong X; Pan B; Liu P; Zhang Y; Huang Y; Su J; Willard B; Zheng L
Diabetes Metab Res Rev; 2012 Feb; 28(2):186-95. PubMed ID: 21928330
[TBL] [Abstract][Full Text] [Related]
7. Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.
Golizeh M; Lee K; Ilchenko S; Ösme A; Bena J; Sadygov RG; Kashyap SR; Kasumov T
Free Radic Biol Med; 2017 Dec; 113():461-469. PubMed ID: 29079528
[TBL] [Abstract][Full Text] [Related]
8. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice.
Holvoet P; Danloy S; Collen D
Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000
[TBL] [Abstract][Full Text] [Related]
9. Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.
Katulanda GW; Katulanda P; Adler AI; Peiris SR; Draisey I; Wijeratne S; Sheriff R; Matthews DR; Shine B
Ann Clin Biochem; 2010 Jan; 47(Pt 1):29-34. PubMed ID: 19952033
[TBL] [Abstract][Full Text] [Related]
10. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
[TBL] [Abstract][Full Text] [Related]
11. Saturated fatty acid, but not cholesterol, regulates apolipoprotein AI gene expression by posttranscriptional mechanism.
Srivastava RA
Biochem Mol Biol Int; 1994 Sep; 34(2):393-402. PubMed ID: 7849650
[TBL] [Abstract][Full Text] [Related]
12. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
[TBL] [Abstract][Full Text] [Related]
14. Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.
Bach-Ngohou K; Ouguerram K; Frénais R; Maugère P; Ripolles-Piquer B; Zaïr Y; Krempf M; Bard JM
J Pharmacol Exp Ther; 2005 Oct; 315(1):363-9. PubMed ID: 16014756
[TBL] [Abstract][Full Text] [Related]
15. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients.
Yang LY; Yu CG; Wang XH; Yuan SS; Zhang LJ; Lang JN; Zhao D; Feng YM
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645936
[TBL] [Abstract][Full Text] [Related]
17. HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications.
Li Y; Zhao M; He D; Zhao X; Zhang W; Wei L; Huang E; Ji L; Zhang M; Willard B; Fu Z; Wang L; Pan B; Zheng L; Ji L
Lipids Health Dis; 2016 Apr; 15():76. PubMed ID: 27074994
[TBL] [Abstract][Full Text] [Related]
18. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
[TBL] [Abstract][Full Text] [Related]
19. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study.
Wilkins JT; Seckler HS; Rink J; Compton PD; Fornelli L; Thaxton CS; LeDuc R; Jacobs D; Doubleday PF; Sniderman A; Lloyd-Jones DM; Kelleher NL
J Am Heart Assoc; 2021 Sep; 10(17):e019890. PubMed ID: 34472376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
